Elsevier

Fertility and Sterility

Volume 98, Issue 3, September 2012, Pages 591-598
Fertility and Sterility

ASRM pages
Endometriosis and infertility: a committee opinion

https://doi.org/10.1016/j.fertnstert.2012.05.031Get rights and content

Women with endometriosis typically present with pelvic pain, infertility, or an adnexal mass, and may require surgery. Treatment of endometriosis in the setting of infertility raises a number of complex clinical questions that do not have simple answers. This document replaces the 2006 ASRM Practice Committee document of the same name.

Section snippets

Endometriosis and infertility

The hypothesis that endometriosis causes infertility or a decrease in fecundity remains controversial. Whereas a reasonable body of evidence demonstrates an association between endometriosis and infertility, a causal relationship has not been clearly established. However, endometriosis can result in adhesions or distorted pelvic anatomy that precludes fertility. The fecundity rate in normal couples is in the range of 15% to 20% per month and decreases with age of the female partner 3, 4. The

Biologic mechanisms that may link endometriosis and infertility

No mechanism has been identified to explain the link between endometriosis and subfertility; however, several mechanisms have been proposed 6, 7, 8. It should be emphasized that none of these mechanisms has been proven to decrease fecundity in women with endometriosis. These mechanisms are briefly discussed below.

Diagnosis and staging

In current clinical practice, a surgical procedure such as laparoscopy is required for a definitive diagnosis of endometriosis. Histologic evaluation is warranted whenever the diagnosis is not apparent on visual inspection at surgery. When addressing whether or not to perform a laparoscopy on a woman presenting with a complaint of infertility, one should consider both the likelihood of the diagnosis of endometriosis as well as potential benefit of treatment. A history and physical examination

Medical therapy for endometriosis

Whereas medical therapy is effective for relieving pain associated with endometriosis, there is no evidence that medical treatment of endometriosis improves fertility. In actuality, fertility is essentially eliminated during treatment because all medical treatments for endometriosis inhibit ovulation. Several options have been suggested for medical treatment: progestins and combined estrogen-progestin therapy, gonadotropin-releasing hormone agonists and antagonists, danazol, and, most recently,

Surgery for endometriosis

In stage I/II endometriosis, laparoscopic ablation of endometrial implants has been associated with a small but significant improvement in live birth rates. Two RCTs have evaluated effectiveness of laparoscopic surgery for Stage I or II endometriosis associated with infertility, with only one study demonstrating benefit 26, 27. Both studies permitted surgical discretion in the intervention regarding excision or ablation. The primary outcomes were slightly different: the Italian study analyzed

Combination medical and surgical therapy

Combination medical and surgical therapy for endometriosis consists of either preoperative or postoperative medical therapy. Although theoretically advantageous, there is no evidence in the literature that combination medical-surgical treatment significantly enhances fertility, and it may unnecessarily delay further fertility therapy. Preoperative therapy is reported to reduce pelvic vascularity and the size of endometriotic implants, thus reducing intraoperative blood loss and decreasing the

Superovulation and intrauterine insemination

Several studies report success with superovulation (SO)/intrauterine insemination (IUI) in the treatment of endometriosis-associated infertility. Review of this subject is complicated as most studies have included women whose endometriosis was “treated” prior to SO/IUI or have included women with unexplained infertility (some of whom are presumed to have minimal endometriosis). In a cross-over RCT among patients with unexplained infertility or surgically corrected endometriosis, the pregnancy

Assisted reproductive technology

A recent report on in vitro fertilization-embryo transfer (IVF-ET) outcomes in the United States indicates that the overall delivery rate per retrieval in infertile women ranges from 44.6% in those under 35 years of age to 14.9% in those 41–42 years of age. The average delivery rate per retrieval for all diagnoses was 33.2%, compared with 39.1% for women with endometriosis (45). This is in contrast to a meta-analysis of observational studies which found that women with endometriosis-associated

Pregnancy outcomes in women with endometriosis

Women with endometriosis have been shown to have adverse obstetrical outcomes compared to those without endometriosis. A Swedish cohort study evaluated 8,922 women diagnosed with endometriosis who delivered 13,090 singleton infants from the national medical birth registry of over 1.4 million singleton births (55). Compared to women without endometriosis, the risk of preterm birth associated with endometriosis among women with ART was 1.24 (95% CI, 0.99–1.57), and among women without ART, 1.37

Decisions among infertile women with endometriosis

Clinical decisions in the management of infertility associated with endometriosis are difficult because many clinical decision points have not been evaluated in RCTs. Moreover, the observational data are conflicting and prevent confident conclusions.

For infertile women with suspected stage I/II endometriosis, a decision must be made whether to perform laparoscopy before offering treatment with clomiphene, gonadotropins, or IVF-ET. Clearly, factors such as the woman's age, duration of

Summary

  • There is insufficient evidence to indicate that resection of endometriomas prior to IVF improves outcomes.

  • IVF success rates in women with endometriosis appear to be diminished compared to women with tubal factor infertility; however, IVF likely maximizes cycle fecundity for those with endometriosis.

  • Women with endometriosis have higher incidences of preterm delivery, pre-eclampsia, antepartum bleeding/placental complications, and cesarean section when compared to women without endometriosis.

Conclusions

  • Female age, duration of infertility, pelvic pain, and stage of endometriosis should be considered when formulating a management plan.

  • The benefit of laparoscopic treatment of minimal or mild endometriosis is insufficient to recommend laparoscopy solely to increase the likelihood of pregnancy.

  • When laparoscopy is performed for other indications, the surgeon may consider safely ablating or excising visible lesions of endometriosis.

  • In younger women (under age 35 years) with stage I/II

Acknowledgments

This report was developed under the direction of the Practice Committee of the American Society for Reproductive Medicine as a service to its members and other practicing clinicians. Although this document reflects appropriate management of a problem encountered in the practice of reproductive medicine, it is not intended to be the only approved standard of practice or to dictate an exclusive course of treatment. Other plans of management may be appropriate, taking into account the needs of the

References (57)

  • K. Pagidas et al.

    Comparison of reoperation for moderate (stage III) and severe (stage IV) endometriosis-related infertility with in vitro fertilization-embryo transfer

    Fertil Steril

    (1996)
  • J.L. Deaton et al.

    A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis

    Fertil Steril

    (1990)
  • L. Fedele et al.

    Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study

    Fertil Steril

    (1992)
  • E. Werbrouck et al.

    No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination

    Fertil Steril

    (2006)
  • K. Barnhart et al.

    Effect of endometriosis on in vitro fertilization

    Fertil Steril

    (2002)
  • S. Soliman et al.

    A randomized trial of in vitro fertilization versus conventional treatment for infertility

    Fertil Steril

    (1993)
  • J.A. Garcia-Velasco et al.

    Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study

    Fertil Steril

    (2004)
  • D. Dicker et al.

    The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer

    Fertil Steril

    (1992)
  • E.S. Surrey et al.

    Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

    Fertil Steril

    (2002)
  • L.M. Chaffkin et al.

    A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin (hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone

    Fertil Steril

    (1991)
  • S.A. Missmer et al.

    Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors

    Am J Epidemiol

    (2004)
  • B.S. Verkauf

    Incidence, symptoms, and signs of endometriosis in fertile and infertile women

    J Fla Med Assoc

    (1987)
  • A. Chandra et al.

    The demography of infertility and the use of medical care for infertility

    Infertil Reprod Med Clin North Am

    (1994)
  • D. Schwartz et al.

    Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS

    N Engl J Med

    (1982)
  • R.S. Schenken

    Treatment of human infertility: the special case of endometriosis

  • S.E. Bulun

    Endometriosis

    N Engl J Med

    (2009)
  • L.C. Giudice

    Clinical practice. Endometriosis

    N Engl J Med

    (2010)
  • M.A. Bedaiwy et al.

    Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial

    Hum Reprod

    (2002)
  • Cited by (480)

    • Chapter 11. Endometriosis-related complications in women undergoing in-vitro fertilization

      2024, Best Practice and Research: Clinical Obstetrics and Gynaecology
    • IVF stimulation protocols and outcomes in women with endometriosis

      2024, Best Practice and Research: Clinical Obstetrics and Gynaecology
    View all citing articles on Scopus

    No reprints will be available.

    Correspondence: Practice Committee, American Society for Reproductive Medicine, 1209 Montgomery Hwy., Birmingham, AL 35216 (E-mail: [email protected]).

    View full text